Related Experiment Videos
Suppression of malignancy targeting cyclic AMP signal transducing proteins
1National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Biochemical Society Transactions
|May 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Protein kinase-a directed antisense therapy of tumor growth in vivo : the antisense effects outlast antisense survival.
Methods in molecular medicine·2011
Autoantibody biomarker opens a new gateway for cancer diagnosis.
Biochimica et biophysica acta·2006
DNA drug design for cancer therapy.
Current pharmaceutical design·2005
Killing the messenger: antisense DNA and siRNA.
Current drug targets·2004
Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.
Annals of the New York Academy of Sciences·2004
Fc-engineering for improved cancer immunotherapy.
Biochemical Society transactions·2026
Where metabolism and virulence meet-sulfoxide reductases as determinants of bacterial survival.
Biochemical Society transactions·2026
Molecular mechanisms of Kir channel gating.
Biochemical Society transactions·2026
Communication is key: combinatorial phosphorylation and functional cross-talk in the RNA polymerase II CTD code.
Biochemical Society transactions·2026
The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting.
Biochemical Society transactions·2026
Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules.
Biochemical Society transactions·2026
Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Primary Cardiac Paraganglioma Management and Resection With Rare Recurrent Metastasis.
JACC. Case reports·2026
Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.
Dalton transactions (Cambridge, England : 2003)·2026
Metal-Phenolic Networks: Emerging Nanoarchitectures for Cancer Therapy.
Angewandte Chemie (International ed. in English)·2026
Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.
Angewandte Chemie (International ed. in English)·2026